Bio-Rad Laboratories BIO
NYSE BIO
$377.40 +13.14 (+3.61%)
At close: Aug 20, 2026 · 2:30 PM UTC

Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (5y) (2015 - 2026)

Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.10 Bn 8.49 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -315.00
Mar 31, 2026 -630.00
Dec 31, 2025 -718.00
Sep 30, 2025 225.00
Jun 30, 2025 -7,685.00
Mar 31, 2025 231.00
Dec 31, 2024 272.00
Mar 31, 2024 122,265.00
Dec 31, 2023 776.00
Sep 30, 2023 39.00
Jun 30, 2023 4.00
Mar 31, 2023 373.00
Dec 31, 2022 591.00
Sep 30, 2022 314.00
Jun 30, 2022 368.00
Mar 31, 2022 686.00
Dec 31, 2021 412.00
Sep 30, 2021 -33.00
Jun 30, 2021 -35.00
Mar 31, 2021 234.00